Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma
暂无分享，去创建一个
C. Porta | M. Burotto | R. Motzer | T. Powles | T. Choueiri | E. Plimack | B. Rini | C. Barrios | M. Grimm | V. Grünwald | Yoshihiko Tomita | B. Escudier | P. Barthélémy | C. Kollmannsberger | D. Castellano | F. Ejzykowicz | F. Donskov | D. McDermott | N. Tannir | H. Gurney | S. George | H. Hammers | M. McHenry | Chung-Wei Lee | Jennifer McCarthy | Y. Tomita